Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in J Virol Retrieve available abstracts of 127 articles: HTML format Text format

Single Articles

March 2010
1. GOTTWEIN JM , Scheel TK, Callendret B, Li YP, et al
   Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. LIU L , Fisher BE, Dowd KA, Astemborski J, et al
   Acceleration of HCV envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. BLACKHAM S , Baillie A, Al-Hababi F, Remlinger K, et al
   Gene Expression Profiling Indicates The Role of Host Oxidative Stress, Apoptosis, Lipid Metabolism and Intracellular Transport Genes in the Replication of Hepatitis C Virus.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. IMHOF I , Simmonds P
   Development of an intergenotypic HCV cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. ZHANG YY , Zhang BH, Ishii K, Liang TJ, et al
   A Novel Function of CD81 in Controlling Hepatitis C Virus Replication.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. NYANGUILE O , Devogelaere B, Vijgen L, Van den Broeck W, et al
   1a/1b Subtype Profiling of non-nucleoside Polymerase Inhibitors of Hepatitis C Virus.
   J Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. KOPP M , Murray CL, Jones CT, Rice CM, et al
   Genetic Analysis of the Carboxy-terminal Region of the Hepatitis C Virus Core Protein.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
8. GOUESLAIN L , Alsaleh K, Horellou P, Roingeard P, et al
   IDENTIFICATION OF GBF1 AS A CELLULAR FACTOR REQUIRED FOR HEPATITIS C VIRUS RNA REPLICATION.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. KASPROWICZ V , Kang YH, Lucas M, Schulze Zur Wiesch J, et al
   HCV sequence variation induces an HCV-specific T cell phenotype analogous to spontaneous resolution.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. HAID S , Windisch MP, Bartenschlager R, Pietschmann T, et al
    Mouse-specific Residues of Claudin-1 limit HCV Genotype 2a Infection in a Human Hepatocyte Cell Line.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
11. LAMONTAGNE J , Pinkerton M, Block TM, Lu X, et al
    Hepatitis B and Hepatitis C virus replication up-regulate serine protease inhibitor Kazal, resulting in cellular resistance to serine protease dependent apoptosis.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. VIDAL-CASTINEIRA JR , Lopez-Vazquez A, Diaz-Pena R, Alonso-Arias R, et al
    EFFECT OF KILLER IMMUNOGLOBULIN-LIKE RECEPTORS (KIR) IN THE RESPONSE TO COMBINED TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. RIPOLI M , D'Aprile A, Quarato G, Sarasin-Filipowicz M, et al
    Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1alpha-mediated glycolytic adaptation.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. NORMAN KL , Sarnow P
    Modulation of Hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. AMAKO Y , Tsukiyama-Kohara K, Katsume A, Hirata Y, et al
    Pathogenesis of hepatitis C virus infection in Tupaia belangeri.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. CATANESE MT , Ansuini H, Graziani R, Huby T, et al
    Role of SR-BI in HCV entry: kinetics and molecular determinants.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. BOUDREAU HE , Emerson SU, Korzeniowska A, Jendrysik MA, et al
    Hepatitis C Viral Proteins induce NADPH Oxidase 4 (Nox4) in a TGF{beta}-dependent manner: A new contributor of HCV-induced oxidative stress.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. DENTZER TG , Lorenz IC, Evans MJ, Rice CM, et al
    Determinants of hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LEMM JA , O'Boyle D 2nd, Liu M, Nower PT, et al
    Identification of Hepatitis C Virus NS5A Inhibitors.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
20. MACHIDA K , Liu JC, McNamara G, Levine A, et al
    Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. JIANG J , Luo G
    Apolipoprotein E but Not B Is Required for the Formation of infectious Hepatitis C Virus Particles.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SCHWARZ AK , Grove J, Hu K, Mee CJ, et al
    Hepatoma cell density promotes Claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. BROERING TJ , Garrity KA, Boatright NK, Sloan SE, et al
    Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HUMPHREYS I , Fleming V, Fabris P, Parker J, et al
    Full length characterisation of hepatitis C Virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. FRIEBE P , Bartenschlager R
    Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and Assembly.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. SIMISTER P , Schmitt M, Geitmann M, Wicht O, et al
    Structural and functional analysis of hepatitis C virus strain JFH1 polymerase.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BROHM C , Steinmann E, Friesland M, Lorenz IC, et al
    Characterization of determinants important for hepatitis C virus p7 function in morphogenesis using trans-complementation.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
28. WHIDBY J , Mateu G, Scarborough H, Demeler B, et al
    Blocking hepatitis C virus infection with a recombinant form of envelope protein 2 ectodomain.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. GONZALEZ VD , Falconer K, Blom KG, Reichard O, et al
    High levels of chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients on HAART is reverted by IFN{alpha} and ribavirin treatment.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GOUTTENOIRE J , Montserret R, Kennel A, Penin F, et al
    An Amphipathic {alpha}-Helix at the C Terminus of Hepatitis C Virus Nonstructural Protein 4B Mediates Membrane Association.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HUGHES M , Gretton S, Shelton H, Brown DD, et al
    A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. TAGUWA S , Kambara H, Omori H, Tani H, et al
    Co-chaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
33. WANG N , Liang Y, Devaraj S, Wang J, et al
    Toll-like Receptor 3 Mediates Establishment of an Antiviral State Against Hepatitis C Virus in Hepatoma Cells.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. BANERJEE A , Saito K, Meyer K, Banerjee S, et al
    Hepatitis C Virus Core Protein and Cellular Protein HAX-1 Promotes 5-Fluorouracil Mediated Hepatocyte Growth Inhibition.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. AI LS , Lee YW, Chen SS
    Characterization of Hepatitis C Virus Core Protein Multimerization and Membrane Envelopment: Revelation of a Cascade of Core-Membrane Interactions.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. MOHD-ISMAIL NK , Deng L, Sukumaran SK, Yu VC, et al
    THE HEPATITIS C VIRUS CORE PROTEIN CONTAINS A BH3 DOMAIN THAT REGULATES APOPTOSIS THROUGH SPECIFIC INTERACTION WITH HUMAN MCL-1.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BORAWSKI J , Troke P, Puyang X, Gibaja V, et al
    Class III phosphatidylinositol-4 kinase alpha & beta are novel host factor regulators of hepatitis C virus replication.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. GOLDEN-MASON L , Palmer BE, Kassam N, Townshend-Bulson L, et al
    NEGATIVE IMMUNE REGULATOR TIM-3 IS OVEREXPRESSED IN HEPATITIS C INFECTION AND ITS BLOCKADE RESCUES DYSFUNCTIONAL CD4+ AND CD8+ T CELLS.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. PACINI L , Graziani R, Bartholomew L, De Francesco R, et al
    Naturally occurring Hepatitis C Virus subgenomic deletions replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. AMAKO Y , Sarkeshik A, Hotta H, Yates J 3rd, et al
    Role of Oxysterol Binding Protein in Hepatitis C Virus infection.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
41. VERA-OTAROLA J , Barria MI, Leon U, Carvallo P, et al
    Is single-strand conformation polymorphism analysis of the full 5'untranslated region an adequate approach to study Hepatitis C virus quasispecies distribution?
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. KANDA T , Steele R, Ray R, Ray RB, et al
    INHIBITION OF INTRAHEPATIC IFN-{gamma} PRODUCTION BY HEPATITIS C VIRUS NON-STRUCTURAL PROTEIN 5A IN TRANSGENIC MICE.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BENEDICTO I , Molina-Jimenez F, Bartosch B, Cosset FL, et al
    Tight junction-associated protein occludin is required for a post-binding step in hepatitis C virus entry and infection.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KUKIHARA H , Moriishi K, Taguwa S, Tani H, et al
    Human VAP-C negatively regulates hepatitis C virus propagation.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PHAN T , Beran RK, Peters C, Lorenz I, et al
    Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-4A enzyme complexes.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. STGELAIS C , Foster TL, Verow M, Atkins E, et al
    Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. WEATHERFORD T , Chavez D, Brasky KM, Lanford RE, et al
    The marmoset model of GB virus B infections: adaptation to host phenotypic variation.
    J Virol. 2009;83:5806-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
48. WEATHERFORD T , Chavez D, Brasky KM, Lemon SM, et al
    Lack of Adaptation of Chimeric GBV-B/Hepatitis C Virus in the Marmoset Model: Possible Effects of Bottleneck.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. MCGIVERN DR , Villanueva RA, Chinnaswamy S, Kao CC, et al
    Impaired Replication of Hepatitis C Virus Containing Mutations in a Conserved NS5B Retinoblastoma Protein-Binding Motif.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. ROTMAN Y , Liang TJ
    Coinfection of Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. IBARRA KD , Pfeiffer JK
    Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
    J Virol. 2009;83:4538-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. UZRI D , Gehrke L
    Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
    J Virol. 2009;83:4174-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
53. LIU Z , Yang F, Robotham JM, Tang H, et al
    A Critical Role of Cyclophilin A and its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the HCV Replication Complex.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. DAHARI H , Sainz B Jr, Perelson AS, Uprichard SL, et al
    Modeling subgenomic HCV RNA kinetics during interferon-{alpha} treatment.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SUGIYAMA K , Suzuki K, Nakazawa T, Funami K, et al
    Genetic Analysis of Hepatitis C Virus with Defective Genome and Its Infectivity in Vitro.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. MEE CJ , Harris HJ, Farquhar MJ, Wilson G, et al
    Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. GOUTTENOIRE J , Castet V, Montserret R, Arora N, et al
    Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. LARREA E , Aldabe R, Gonzalez I, Segura V, et al
    Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells.
    J Virol. 2009;83:3298-311.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
59. CUEVAS JM , Gonzalez-Candelas F, Moya A, Sanjuan R, et al
    The effect of ribavirin on the mutation rate and spectrum of Hepatitis C virus in vivo.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. KECK ZY , Li SH, Xia J, von Hahn T, et al
    Mutations in HCV E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. LIANG H , Russell RS, Yonkers NL, McDonald D, et al
    Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. CUKIERMAN L , Meertens L, Bertaux C, Kajumo F, et al
    Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. HARA H , Aizaki H, Matsuda M, Shinkai-Ouchi F, et al
    Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
64. LOVE RA , Brodsky O, Hickey MJ, Wells PA, et al
    CRYSTAL STRUCTURE OF A NOVEL DIMERIC FORM OF NS5A DOMAIN I PROTEIN FROM HEPATITIS C VIRUS.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
65. STACEY AR , Norris PJ, Qin L, Haygreen EA, et al
    Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. BERAN RK , Lindenbach BD, Pyle AM
    The NS4A Protein from Hepatitis C Virus Promotes RNA-coupled ATP Hydrolysis by the NS3 Helicase.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. JAGANNATHAN P , Osborne CM, Royce C, Manion MM, et al
    Comparisons of CD8+ T Cells Specific for HIV, HCV and CMV Reveal Differences in Frequency, Immunodominance, Phenotype, and IL-2 Responsiveness.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. ENG FJ , Walewski JL, Klepper AL, Fishman SL, et al
    Internal Initiation Stimulates Production of p8 Mini-core, a Member of a Newly-Discovered Family of Hepatitis C Virus Core Protein Isoforms.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
69. KUROKI M , Ariumi Y, Ikeda M, Dansako H, et al
    Arsenic Trioxide Inhibits HCV RNA Replication Through Modulation of the Glutathione Redox System and Oxidative Stress.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. SUZUKI R , Moriishi K, Fukuda K, Shirakura M, et al
    Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: ubiquitin-dependent and ubiquitin-independent but PA28{gamma}-dependent.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. JONES DM , Patel AH, Targett-Adams P, McLauchlan J, et al
    THE HEPATITIS C VIRUS NS4B PROTEIN CAN TRANS-COMPLEMENT VIRAL RNA REPLICATION AND MODULATES PRODUCTION OF INFECTIOUS VIRUS.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. LIU S , Yang W, Shen L, Turner JR, et al
    Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and are Downregulated during Infection to Prevent Superinfection.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. DAVIS M , Sagan SM, Pezacki JP, Evans DJ, et al
    Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses.
    J Virol. 2008;82:11824-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
74. BARIL M , Racine ME, Penin F, Lamarre D, et al
    MAVS dimer is a crucial signaling component of innate immunity and the target of HCV NS3/4A protease.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. WILKINSON J , Radkowski M, Laskus T
    HEPATITIS C VIRUS NEUROINVASION: IDENTIFICATION OF INFECTED CELLS.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. HELBIG KJ , Ruszkiewicz A, Lanford RE, Berzsenyi MD, et al
    Differential expression of the CXCR3 ligands in chronic hepatitis C, and their modulation by HCV in vitro.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
77. PYBUS OG , Barnes E, Taggart R, Lemey P, et al
    The Genetic History Of The Hepatitis C Virus In East Asia.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. YUKSEK K , Chen WL, Chien D, Ou JH, et al
    UBIQUITIN-INDEPENDENT DEGRADATION OF HEPATITIS C VIRUS F PROTEIN.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. PAEK KY , Kim CS, Park SM, Kim JH, et al
    An RNA-binding protein hnRNP D modulates IRES-dependent translation of HCV RNA.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. HEYDTMANN M
    Macrophages in Hepatitis B and Hepatitis C Virus Infection.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. MONDAL T , Ray U, Manna AK, Gupta R, et al
    Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. GROVE J , Nielsen S, Zhong J, Bassendine MF, et al
    Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
83. SALLOUM S , Oniangue-Ndza C, Neumann-Haefelin C, Hudson L, et al
    Escape from HLA-B*08 restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. VASSILAKI N , Friebe P, Meuleman P, Kallis S, et al
    Role of Hepatitis C Virus Core+1 Open Reading Frame and Core Cis-Acting RNA Elements in Viral RNA Translation and Replication.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. DENG L , Adachi T, Kitayama K, Bungyoku Y, et al
    Hepatitis C Virus Infection Induces Apoptosis through a Bax-triggered, Mitochondria-mediated, Caspase-3-dependent Pathway.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. KANDA T , Steele R, Ray R, Ray RB, et al
    Hepatitis C virus core protein augments androgen-receptor mediated signaling.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
87. YOUN JW , Hu YW, Tricoche N, Pfahler W, et al
    Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. MOONKA D , Milkovich KA, Rodriguez B, Abouljoud M, et al
    Hepatitis C specific T cell IFN-{gamma} and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. RAMALINGAM RK , Meyer-Olson D, Shoukry NH, Bowen DG, et al
    Real-time PCR kinetic analysis of peripheral blood and intrahepatic HCV specific T-cells after HCV challenge.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. PAREDES AM , Blight KJ
    Genetic interaction between hepatitis C virus NS4B and NS3 important for RNA replication.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WOLK B , Buchele B, Moradpour D, Rice CM, et al
    A dynamic view of hepatitis C virus replication complexes.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
92. BADR G , Bedard N, Abdel-Hakeem MS, Trautmann L, et al
    Early Interferon Therapy for HCV Rescues Poly-functional long-lived CD8+ Memory T Cells.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ARIUMI Y , Kuroki M, Dansako H, Abe KI, et al
    ATM and Chk2, DNA damage sensors, are required for hepatitis C virus RNA replication.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. RADZIEWICZ H , Ibegbu CC, Hon H, Osborn MK, et al
    Impaired HCV specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SHIN EC , Capone S, Cortese R, Colloca S, et al
    The Kinetics of Hepatitis C Virus-Specific CD8 T Cell Responses in the Blood Mirrors Those in the Liver in Acute Hepatitis C Virus Infection.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. MEUNIER JC , Russell RS, Engle RH, Faulk KN, et al
    Apolipoprotein C1 association with Hepatitis C Virus.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. XU Z , Fan X, Xu Y, Di Bisceglie AM, et al
    Comparative Analysis of Near Full-length Hepatitis C Viral Quasispecies in Patients Experiencing Viral Breakthrough during Antiviral Therapy: Clustered Mutations in Three Functional Genes E2, NS2 and NS5a.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. DIVINEY S , Tuplin A, Struthers M, Armstrong V, et al
    A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
99. BRAZZOLI M , Bianchi A, Filippini S, Weiner A, et al
    CD81 is a central regulator of cellular events required for HCV infection of human hepatocytes.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. FARQUHAR MJ , Harris HJ, Diskar M, Jones S, et al
     Protein Kinase A dependent step(s) in Hepatitis C virus entry and infectivity.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LAI CK , Jeng KS, Machida K, Lai MM, et al
     Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. OKAMOTO K , Mori Y, Komoda Y, Okamoto T, et al
     Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. BUKH J , Thimme R, Meunier JC, Faulk K, et al
     Previously infected chimpanzees are not consistently protected from reinfection or persistent infection following reexposure to the identical hepatitis C virus strain.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. CHANG J , Guo JT, Jiang D, Guo H, et al
     Liver Specific microRNA, miR-122, Enhances the Replication of Hepatitis C Virus in Non-hepatic Cells.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. MASAKI T , Suzuki R, Murakami K, Aizaki H, et al
     Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
106. LIN Y , Kwon T, Polo J, Zhu YF, et al
     The induction of broad CD4+ and CD8+ T cell responses and cross-neutralizing antibodies against the hepatitis C virus (HCV) by vaccinating with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1/
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. MA Y , Yates J, Liang Y, Lemon SM, et al
     NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LI H , Thomassen LV, Majid A, McMahon BJ, et al
     Investigation of putative multi-subtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. STEINMANN E , Brohm C, Kallis S, Bartenschlager R, et al
     Efficient Trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-like Particles.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. CAETANO J , Martinho A, Paiva A, Pais B, et al
     Differences in HCV-specific CD8 T cell phenotype during pegylated interferon-{alpha} and ribavirin treatment are related with response to antiviral therapy in hepatitis C chronically infected patients.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
111. MUNOZ DE RUEDA P , Casado J, Paton R, Quintero D, et al
     Prospective studies of mutations in the E2-PePHD, NS5A-PKRBD, NS5A-ISDR and NS5A-V3 regions of hepatitis C virus genotype 1 and their relationship to peginterferon and ribavirin treatment response.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. MACHIDA K , Kondo Y, Huang J, Chen YC, et al
     HCV-induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. KECK ZY , Li TK, Xia J, Gal-Tanamy M, et al
     Definition of a Conserved Immunodominant Domain on HCV E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. ZHANG Z , Harris D, Pandey VN
     The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C Virus.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. KECK ZY , Olson O, Gal-Tanamy M, Xia J, et al
     A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. YANG F , Robotham JM, Nelson HB, Irsigler A, et al
     Cyclophilin A is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine A Resistance In Vitro.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
117. AIZAKI H , Morikawa K, Fukasawa M, Hara H, et al
     A Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. BOWEN DG , Shoukry NH, Grakoui A, Fuller MJ, et al
     Variable patterns of programmed death-1 (PD-1) expression on fully functional memory T cells following spontaneous resolution of hepatitis C virus infection.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. HARRIS HJ , Farquhar MJ, Mee CJ, Davis C, et al
     CD81 and Claudin 1 co-receptor association: a role in hepatitis C virus entry.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. EBINUMA H , Nakamoto N, Li Y, Price DA, et al
     Identification and in-vitro expansion of functional antigen-specific CD25+FoxP3+ regulatory T-cells in hepatitis C virus infection.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
121. TILTON JC , Manion MM, Luskin MR, Johnson AJ, et al
     HIV Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Interferon-{alpha} Production In Vitro.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
122. MEERTENS L , Bertaux C, Cukierman L, Cormier E, et al
     The tight junction proteins claudin-1, -6 and -9 are entry cofactors for the Hepatitis C virus.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. OKAMOTO T , Omori H, Kaname Y, Abe T, et al
     A Single Amino Acid Mutation in Hepatitis C Virus NS5A Disrupting FKBP8 Interaction Impairs Viral Replication.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. NEUMANN-HAEFELIN C , Frick DN, Wang JJ, Pybus OG, et al
     Analysis of the evolutionary forces in an immunodominant CD8 epitope in the hepatitis C virus at a population level.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. BARTH H , Schnober EK, Neumann-Haefelin C, Thumann C, et al
     Scavenger Receptor Class B is Required for Hepatitis C Virus Uptake and Cross-presentation by Human Dendritic Cells.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. SAITO K , Ait-Goughoulte M, Truscott SM, Meyer K, et al
     HEPATITIS C VIRUS INHIBITS CELL SURFACE EXPRESSION OF HLA-DR, PREVENTS DENDRITIC CELL MATURATION AND INDUCES IL-10 PRODUCTION.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. YERLY D , Heckerman D, Allen TM, Chisholm JV 3rd, et al
     Increased CTL epitope variant cross-recognition and functional avidity are associated with HCV clearance.
     J Virol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: